Maaike Boonstra

Rituximab in early systemic sclerosis

Maaike Boonstra, J. Meijs, Annemarie L Dorjée et al. · RMD Open · 2017 · 69 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study

Sandra van Bijnen, Jeska de Vries‐Bouwstra, C.H.M. van den Ende et al. · Annals of the Rheumatic Diseases · 2020 · 55 citations

Medicine, Clinical Sciences, Cell Therapy +13

Antisense Long Non-Coding RNAs Are Deregulated in Skin Tissue of Patients with Systemic Sclerosis

Tobias Messemaker, Loubna Chadli, Guoshuai Cai et al. · Journal of Investigative Dermatology · 2017 · 50 citations · Full text

Medicine, Dermatology, Molecular Genetics +13

Association of Anti–Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti–Topoisomerase I–Positive Systemic Sclerosis

Maaike Boonstra, Jaap Bakker, Annette Grummels et al. · Arthritis & Rheumatology · 2020 · 41 citations · Full text

Life Sciences, Immunology, Pathology +14

Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis

Nina M. van Leeuwen, Maaike Boonstra, Jaap Bakker et al. · Arthritis & Rheumatology · 2021 · 31 citations · Full text

Life Sciences, Immunology, Internal Medicine +17